Les Funtleyder's most recent trade in Applied Therapeutics Inc was a trade of 150,000 Common Stock done . Disclosure was reported to the exchange on June 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Applied Therapeutics Inc | Les Funtleyder | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 150,000 | 787,121 (4%) | 0% | 0 | Common Stock | |
| Applied Therapeutics Inc | Les Funtleyder | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 150,000 | 937,121 (5%) | 0% | 0 | Common Stock | |
| Applied Therapeutics Inc | Les Funtleyder | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2025 | 350,000 | 740,459 (3%) | 1% | 0 | Common Stock | |
| Applied Therapeutics Inc | Les Funtleyder | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 0.44 per share. | 04 Mar 2025 | 14,502 | 390,459 (2%) | 0% | 0.4 | 6,381 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 0.61 per share. | 06 Feb 2025 | 22,950 | 404,961 (2%) | 0% | 0.6 | 14,000 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Funtleyder Les | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 150,000 | 427,911 (2%) | 0% | 0 | Common Stock | |
| Reviva Pharmaceuticals Hol... | Les Funtleyder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 8,200 | 8,200 | - | - | Stock Option (right to buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.83 per share. | 22 Aug 2024 | 13,530 | 277,911 (1%) | 0% | 5.8 | 78,880 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.32 per share. | 06 Jun 2024 | 16,980 | 291,441 (1%) | 0% | 4.3 | 73,354 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.39 per share. | 14 Mar 2024 | 28,727 | 308,421 (1%) | 0% | 5.4 | 154,839 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2023 | 300,000 | 337,148 (1%) | 1% | 0 | Common Stock | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 20,000 | 37,148 (0%) | 0% | 0 | Common Stock | |
| Reviva Pharmaceuticals Hol... | Les Funtleyder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Nov 2022 | 3,900 | 3,900 | - | - | Stock Option (right to buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 20,460 | 20,460 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 20,460 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 16,500 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 16,500 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 10,230 | 10,230 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 10,230 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
| Reviva Pharmaceuticals Hol... | Les Funtleyder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2021 | 5,300 | 5,300 | - | - | Stock Option (right to buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2020 | 30,000 | 40,502 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 01 Oct 2020 | 30,000 | 47,148 (0%) | 0% | 4.7 | 141,000 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 20.03 per share. | 01 Oct 2020 | 22,671 | 24,477 (0%) | 0% | 20.0 | 454,100 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 20.07 per share. | 01 Oct 2020 | 5,976 | 17,148 (0%) | 0% | 20.1 | 119,938 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 20.75 per share. | 01 Oct 2020 | 1,353 | 23,124 (0%) | 0% | 20.8 | 28,075 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Aug 2020 | 20,000 | 70,502 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 21 Aug 2020 | 20,000 | 37,148 (0%) | 0% | 4.7 | 94,000 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 23.42 per share. | 21 Aug 2020 | 13,539 | 23,609 (0%) | 0% | 23.4 | 317,083 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 24.18 per share. | 21 Aug 2020 | 6,461 | 17,148 (0%) | 0% | 24.2 | 156,227 | Common Stock |